Functional variants of the P2RX7 gene, aseptic osteolysis, and revision of the total hip arthroplasty: A preliminary study

Human Immunology

Volumn 71, Issue 2, 2010, Pages 201-205

  Mrazek, F ^a   Gallo, J ^a   Stahelova, A ^a   Petrek, M ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Aseptic loosening; Bone turnover; Genetic polymorphism; Osteolysis; Purinergic signaling

Indexed keywords

CELL PROTEIN; PURINERGIC P2X RECEPTOR LIGAND GATED ION CHANNEL 7; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASEPTIC OSTEOLYSIS; BONE DISEASE; BONE TURNOVER; CONTROLLED STUDY; CZECH REPUBLIC; DISEASE SEVERITY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTHESIS FAILURE; PROSTHESIS LOOSENING; REOPERATION; SINGLE NUCLEOTIDE POLYMORPHISM; TOTAL HIP PROSTHESIS;

ADULT; ARTHROPLASTY, REPLACEMENT, HIP; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HIP PROSTHESIS; HUMANS; MALE; MIDDLE AGED; OSTEOLYSIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTOPERATIVE COMPLICATIONS; PROSTHESIS FAILURE; RECEPTORS, PURINERGIC P2; REOPERATION;

EID: 74449083980     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2009.10.013     Document Type: Article

References (36)

1. Learmonth I.D., Young C., and Rorabeck C. The operation of the century: Total hip replacement. Lancet 370 (2007) 1508-1519
2. Kurtz S., Ong K., Lau E., Mowat F., and Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 89 (2007) 780-785
3. Malchau H., Herberts P., Eisler T., Garellick G., and Soderman P. The Swedish total hip replacement register. J Bone Joint Surg Am 84A Suppl 2 (2002) 2-20
4. Ulrich S.D., Seyler T.M., Bennett D., Delanois R.E., Saleh K.J., Thongtrangan I., et al. Total hip arthroplasties: What are the reasons for revision?. Int Orthop 32 (2008) 597-604
5. Gallo J., Raska M., Mrazek F., and Petrek M. Bone remodeling, particle disease and individual susceptibility to periprosthetic osteolysis. Physiol Rev 57 (2008) 339-349
6. Goodman S.B., Gomez Barrena E., Takagi M., and Konttinen Y.T. Biocompatibility of total joint replacements: A review. J Biomed Mater Res A 90 (2009) 603-618
7. Tuan R.S., Lee F.Y., Konttinen Y.T., Wilkinson J.M., Smith R.L., and Implant wear symposium 2007 Biologic Work Group. What are the local and systemic biologic reactions and mediators to wear debris, and what host factors determine or modulate the biologic response to wear particles?. J Am Acad Orthop Surg 16 Suppl 1 (2008) S42-S48
8. Chen L., and Brosnan C.F. Regulation of immune response by P2X7 receptor. Crit Rev Immunol 26 (2006) 499-513
9. Grol M.W., Panupinthu N., Korcok J., Sims S.M., and Dixon S.J. Expression, signaling, and function of P2X7 receptors in bone. Purinergic Signal 5 (2009) 205-221
10. Ferrari D., Pizzirani C., Adinolfi E., Lemoli R.M., Curti A., Idzko M., et al. The P2X7 receptor: A key player in IL-1 processing and release. J Immunol 176 (2006) 3877-3883
11. Labasi J.M., Petrushova N., Donovan C., McCurdy S., Lira P., Payette M.M., et al. Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response. J Immunol 168 (2002) 6436-6445
12. Glas R., Sauter N.S., Schulthess F.T., Shu L., Oberholzer J., and Maedler K. Purinergic P2X(7) receptors regulate secretion of interleukin-1 receptor antagonist and beta cell function and survival. Diabetologia 52 (2009) 1579-1588
13. Panupinthu N., Rogers J.T., Zhao L., Solano-Flores L.P., Possmayer F., Sims S.M., et al. P2X7 receptors on osteoblasts couple to production of lysophosphatidic acid: A signaling axis promoting osteogenesis. J Cell Biol 181 (2008) 859-871
14. Korcok J., Raimundo L.N., Ke H.Z., Sims S.M., and Dixon S.J. Extracellular nucleotides act through P2X7 receptors to activate NF-kappaB in osteoclasts. J Bone Miner Res 19 (2004) 642-651
15. Fuller S.J., Stokes L., Skarratt K.K., Gu B.J., and Wiley J.S. Genetics of the P2X7 receptor and human disease. Purinergic Signal 5 (2009) 257-262
16. Gu B.J., Sluyter R., Skarratt K.K., Shemon A.N., Dao-Ung L.P., Fuller S.J., et al. An Arg307 to Gln polymorphism within the ATP-binding site causes loss of function of the human P2X7 receptor. J Biol Chem 279 (2004) 31287-31295
17. Saleh K.J., Holtzman J., Gafni A., Saleh L., Davis A., Resig S., et al. Reliability and Intraoperative validity of preoperative assessment of standardized plain radiographs in predicting bone loss at revision hip surgery. J Bone Joint Surg Am 83A (2001) 1040-1046
18. Engh C.A., Massin P., and Suthers K.E. Roentgenographic assessment of the biologic fixation of. Porous-surfaced femoral components. Clin Orthop Relat Res 257 (1990) 107-128
19. Udomkiat P., Wan Z., and Dorr L.D. Comparison of preoperative radiographs and Intraoperative findings of fixation of hemispheric porous-coated sockets. J Bone Joint Surg Am 83A (2001) 1865-1870
20. Gallo J., Havranek V., and Zapletalova J. Risk factors for accelerated polyethylene wear and osteolysis in ABG I total hip arthroplasty. Int Orthop (2009 February 13) [Epub ahead of print]
21. Bunce M., O'Neill C.M., Barnardo M.C., Krausa P., Browning M.J., Morris P.J., et al. Phototyping: Comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 and DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 46 (1995) 355-367
22. Dorey F.J. Survivorship analysis of surgical treatment of the hip in young patients. Clin Orthop Relat Res 418 (2004) 23-28
23. Gordon A., Kiss-Toth E., Stockley I., Eastell R., and Wilkinson J.M. Polymorphisms in the Interleukin-1 receptor antagonist and interleukin-6 genes affect risk of osteolysis in Patients with total hip arthroplasty. Arthritis Rheum 58 (2008) 3157-3165
24. Gordon A., Southam L., Loughlin J., Wilson A.G., Stockley I., Hamer A.J., et al. Variation in the secreted frizzled-related protein-3 gene and risk of osteolysis and heterotopic ossification after total hip arthroplasty. J Orthop Res 25 (2007) 1665-1670
25. Malik M.H., Bayat A., Jury F., Ollier W.E., and Kay P.R. Genetic susceptibility to hip arthroplasty. Failure-association with the RANK/OPG pathway. Int Orthop 30 (2006) 177-181
26. Malik M.H., Bayat A., Jury F., Kay P.R., and Ollier W.E. Genetic susceptibility to total hip. Arthroplasty failure-positive association with mannose-binding lectin. J Arthroplasty 22 (2007) 265-270
27. Malik M.H., Jury F., Bayat A., Ollier W.E., and Kay P.R. Genetic susceptibility to total hip. arthroplasty failure: A preliminary study on the influence of matrix metalloproteinase 1, Interleukin-6 polymorphisms and vitamin D receptor. Ann Rheum Dis 66 (2007) 1116-1120
28. Kolundzic R., Orlic D., Trkulja V., Pavelic K., and Troselj K.G. Single nucleotide polymorphisms in the interleukin-6 gene promoter, tumor necrosis factor-alpha gene promoter, and transforming growth factor-beta1 gene signal sequence as predictors of time to onset of aseptic loosening after total hip arthroplasty: Preliminary study. J Orthop Sci 11 (2006) 592-600
29. Ke H.Z., Qi H., Weidema A.F., Zhang Q., Panupinthu N., Crawford D.T., et al. Deletion of the P2X7 nucleotide receptor reveals its regulatory roles in bone formation and resorption. Mol Endocrinol 17 (2003) 1356-1367
30. Li J., Liu D., Ke H.Z., Duncan R.L., and Turner C.H. The P2X7 nucleotide receptor mediates skeletal mechanotransduction. J Biol Chem 280 (2005) 42952-42959
31. Panupinthu N., Zhao L., Possmayer F., Ke H.Z., Sims S.M., and Dixon S.J.P. 2X7 nucleotide receptors mediate blebbing in osteoblasts through a pathway involving lysophosphatidic acid. J Biol Chem 282 (2007) 3403-3412
32. Armstrong S., Pereverzev A., Dixon S.J., and Sims S.M. Activation of P2X7 receptors causes isoform-specific translocation of protein kinase C in osteoclasts. J Cell Sci 122 (2009) 136-144
33. Solle M., Labasi J., Perregaux D.G., Stam E., Petrushova N., Koller B.H., et al. Altered cytokine production in mice lacking P2X(7) receptors. J Biol Chem 276 (2001) 125-132
34. Ohlendorff S.D., Tofteng C.L., Jensen J.E., Petersen S., Civitelli R., Fenger M., et al. Single nucleotide polymorphisms in the P2X7 gene are associated to fracture risk and to effect of estrogen treatment. Pharmacogenet. Genomics 17 (2007) 555-567
35. Gallo J., and Petrek M. Association of interleukin-1 receptor antagonist and interleukin-6 polymorphisms with osteolysis after total hip arthroplasty: Comment on the article by Gordon, et al. Arthritis Rheum 60 (2009) 1563-1564
36. Little J., Higgins J.P., Ioannidis J.P., Moher D., Gagnon F., von Elm E., et al. STrengthening the REporting of Genetic Association Studies (STREGA): An extension of the STROBE statement. PLoS Med 6 (2009) e22